Obsidian Therapeutics initiated at Outperform by William Blair
William Blair initiated coverage of Obsidian Therapeutics with an Outperform rating, per Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.